Q7a(中英文对照)
FDA原料药GMP指南
Table of Contents |
目录 |
1. INTRODUCTION |
1. 简介 |
1.1 Objective |
1.1目的 |
1.2 Regulatory Applicability |
1.2法规的适用性 |
1.3 Scope |
1.3范围 |
|
|
2. QUALITY MANAGEMENT |
2.质量管理 |
2.1 Principles |
2.1总则 |
2.2 Responsibilities of the Quality Unit(s) |
2.2质量部门的责任 |
2.3 Responsibility for Production Activities |
2.3生产作业的职责 |
2.4 Internal Audits (Self Inspection) |
2.4内部审计(自检) |
2.5 Product Quality Review |
2.5产品质量审核 |
|
|
3. PERSONNEL |
3. 人员 |
3.1 Personnel Qualifications |
3.人员的资质 |
3.2 Personnel Hygiene |
3.2 人员卫生 |
3.3 Consultants |
3.3 顾问 |
|
|
4. BUILDINGS AND FACILITIES |
4. 建筑和设施 |
4.1 Design and Construction |
4.1 设计和结构 |
4.2 Utilities |
4.2 公用设施 |
4.3 Water |
4.3 水 |
4.4 Containment |
4.4 限制 |
4.5 Lighting |
4.5 照明 |
4.6 Sewage and Refuse |
4.6 排污和垃圾 |
4.7 Sanitation and Maintenance |
4.7 卫生和保养 |
|
|
5. PROCESS EQUIPMENT |
5. 工艺设备 |
5.1 Design and Construction |
5.1 设计和结构 |
5.2 Equipment Maintenance and Cleaning |
5.2 设备保养和清洁 |
5.3 Calibration |
5.3 校验 |
5.4 Computerized Systems |
5.4 计算机控制系统 |
|
|
6. DOCUMENTATION AND RECORDS |
6. 文件和记录 |
6.1 Documentation System and Specifications |
6.1 文件系统和质量标准 |
6.2 Equipment cleaning and Use Record |
6.2 设备的清洁和使用记录 |
6.3 Records of Raw Materials, Intermediates, API Labeling and Packaging Materials |
6.3 原料、中间体、原料药的标签和包装材料的记录 |
6.4 Master Production Instructions (Master Production and Control Records) |
6.4 生产工艺规程(主生产和控制记录) |
6.5 Batch Production Records (Batch Production and Control Records) |
6.5 批生产记录(批生产和控制记录) |
6.6 Laboratory Control Records |
6.6 实验室控制记录 |
6.7 Batch Production Record Review |
6.7批生产记录审核 |
|
|
7. MATERIALS MANAGEMENT |
7. 物料管理 |
7.1 General Controls |
7.1 控制通则 |
7.2 Receipt and Quarantine |
7.2接收和待验 |
7.3 Sampling and Testing of Incoming Production Materials |
7.3 进厂物料的取样与测试 |
7.4 Storage |
7.4储存 |
7.5 Re-evaluation |
7.5复验 |
|
|
8. PRODUCTION AND IN-PROCESS CONTROLS |
8. 生产和过程控制 |
8.1 Production Operations |
8.1 生产操作 |
8.2 Time Limits |
8.2 时限 |
8.3 In-process Sampling and Controls |
8.3 工序取样和控制 |
8.4 Blending Batches of Intermediates or APIs |
8.4 中间体或原料药的混批 |
8.5 Contamination Control |
8.5 污染控制 |
|
|
9. PACKAGING AND IDENTIFICATION LABELING OF APIs AND INTERMEDIATES |
9. 原料药和中间体的包装和贴签 |
9.1 General |
9.1 总则 |
9.2 Packaging Materials |
9.2 包装材料 |
9.3 Label Issuance and Control |
9.3 标签发放与控制 |
9.4 Packaging and Labeling Operations |
9.4 包装和贴签操作 |
|
|
10. STORAGE AND DISTRIBUTION |
10.储存和分发 |
10.1 Warehousing Procedures |
10.1 入库程序 |
10.2 Distribution Procedures |
10.2 分发程序 |
|
|
11. LABORATORY CONTROLS |
11.实验室控制 |
11.1 General Controls |
11.1 控制通则 |
11.2 Testing of Intermediates and APIs |
11.2 中间体和原料药的测试 |
11.3 Validation of Analytical Procedures |
11.3 分析方法的验证 |
11.4 Certificates of Analysis |
11.4 分析报告单 |
11.5 Stability Monitoring of APIs |
11.5 原料药的稳定性监测 |
11.6 Expiry and Retest Dating |
11.6 有效期和复验期 |
11.7 Reserve/Retention Samples |
11.7 留样 |
|
|
12. VALIDATION |
12.验证 |
12.1 Validation Policy |
12.1 验证方针 |
12.2 Validation Documentation |
12.2 验证文件 |
12.3 Qualification |
12.3 确认 |
12.4 Approaches to Process Validation |
12.4 工艺验证的方法 |
12.5 Process Validation Program |
12.5 工艺验证的程序 |
12.6 Periodic Review of Validated Systems |
12.6验证系统的定期审核 |
12.7 Cleaning Validation |
12.7 清洗验证 |
12.8 Validation of Analytical Methods |
12.8 分析方法的验证 |
|
|
13. CHANGE CONTROL |
13.变更的控制 |
|
|
14. REJECTION AND RE-USE OF MATERIALS |
14.拒收和物料的再利用 |
14.1 Rejection |
14.1 拒收 |
14.2 Reprocessing |
14.2 返工 |
14.3 Reworking |
14.3 重新加工 |
14.4 Recovery of Materials and Solvents |
14.4 物料与溶剂的回收 |
14.5 Returns |
14.5 退货 |
|
|
15. COMPLAINTS AND RECALLS |
15.投诉与召回 |
|
|
16. CONTRACT MANUFACTURERS (INCLUDING LABORATORIES) |
16.协议生产商(包括实验室) |
|
|
17. AGENTS, BROKERS, TRADERS, DISTRIBUTORS, REPACKERS, AND RELABELLERS |
17.代理商、经纪人、贸易商、经销商、重新包装者和重新贴签者 |
17.1 Applicability |
17.1适用性 |
17.2 Traceability of Distributed APIs and Intermediates |
17.2已分发的原料药和中间体的可追溯性 |
17.3 Quality Management |
17.3质量管理 |
17.4 Repackaging, Relabeling, and Holding of APIs and Intermediates |
17.4原料药和中间体的重新包装、重新贴签和待检 |
17.5 Stability |
17.5稳定性 |
17.6 Transfer of Information |
17.6 信息的传达 |
17.7 Handling of Complaints and Recalls |
17.7 投诉和召回的处理 |
17.8 Handling of Returns |
17.8 退货的处理 |
|
|
18. Specific Guidance for APIs Manufactured by Cell Culture/Fermentation |
18. 用细胞繁殖/发酵生产的原料药的特殊指南 |
18.1 General |
18.1 总则 |
18.2 Cell Bank Maintenance and Record Keeping |
18.2细胞库的维护和记录的保存 |
18.3 Cell Culture/Fermentation |
18.3细胞繁殖/发酵 |
18.4 Harvesting, Isolation and Purification |
18.4收取、分离和精制 |
18.5 Viral Removal/Inactivation steps |
18.5 病毒的去除/灭活步骤 |
|
|
19. APIs for Use in Clinical Trials |
19. 用于临床研究的原料药 |
19.1 General |
19.1 总则 |
19.2 Quality |
19.2 质量 |
19.3 Equipment and Facilities |
19.3 设备和设施 |
19.4 Control of Raw Materials |
19.4 原料的控制 |
19.5 Production |
19.5 生产 |
19.6 Validation |
19.6 验证 |
19.7 Changes |
19.7 变更 |
19.8 Laboratory Controls |
19.8 实验室控制 |
19.9 Documentation |
19.9 文件 |
|
|
20. Glossary |
20. 术语 |
深圳施迈特医药管理咨询有限公司, 地址:深圳市宝安中心区荣超滨海大厦A座2109,2110 电话:0755-27307362 传真:0755-27307349
Add: R 2109,2110, Block A, Rongchao Binhai Building, Bao’an Disitrict, Shenzhen Tel:0755-27307362 Fax:0755-27307349
Web: www.smart-pharmservice.com